News Trump 'already understands' need to incentivise R&D, says Me... Frazier takes swipe at price-hiking generics firms.
News Merrimack goes back to drawing board with $1bn Ipsen sell-of... Merrimack sells off Onivyde and generic cancer drug
News IBM Watson, Illumina collaborate on cancer genetics decision... IBM Watson for Genomics will inform cancer treatment decisions by analysing Illumina's genetic data.
News Owlstone seals further funding for cancer breathalyser Money will go towards commercial launch of its R&D services.
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
